Justin A. Renz
Chief Financial Officer
biopharmaceutical technology
Cardiome Pharma Corp
Germany
Biography
Justin A. Renz is Chief Financial Officer of the Company. He has extensive experience in the biopharmaceutical industry. He most recently served as executive vice-president, chief financial officer and treasurer at Karyopharm Therapeutics, which he joined in August, 2014, where he led core business and finance functions. Prior to Karyopharm, Mr. Renz was executive vice-president, chief financial officer and treasurer at Zalicus Inc. (formerly CombinatoRx Inc.), which he joined in September, 2006. He oversaw multiple rounds of equity and debt financing and led the company's asset monetization strategy and two reverse mergers. Prior to Zalicus, Mr. Renz served in senior finance and accounting roles at Serono Inc. and Coley Pharmaceutical Group Inc.
Research Interest
pharmaceutical technology business and administration
